Glucagon-like peptide-1 (GLP-1) has been shown to be a potent stress-regulating neuropeptide in animal models, but little is known about whether genetic polymorphisms that influence this peptide influence stress responses in humans. We therefore explored whether a missense mutation (rs1042044) in the GLP-1 receptor was associated with morning and evening salivary cortisol levels in preschool aged children. Morning and evening saliva samples and individual buccal swabs for DNA extraction were collected from seventy-seven preschool aged children. Salivary cortisol was assayed using a time-resolved fluorescence immunoassay with fluorometric end-point detection (DELFIA), and the rs1042044 single nucleotide polymorphism (SNP) was genotyped using allele specific TaqMan probes. Children homozygous for the phenylalanine (C) substitution in the GLP-1R gene had significantly higher morning salivary cortisol levels than children with other GLP-1R genotypes (p = 0.029). Additionally, children with one or two copies of the phenylalanine (C) allele had significantly higher morning cortisol levels compared to children homozygous for the leucine (A) allele (p = 0.008). Our results identify associations between a novel genetic variant of GLP-1R and hypothalamus-pituitary-adrenal (HPA) axis regulation. This polymorphism may have functional significance in stress-related psychiatric disorders.
Introduction
Glucagon-like peptide-1 (GLP-1) is a peptide of thirty amino acids produced in the intestines, the pancreas, and the brain (Drucker and Asa, 1998) . Functioning both as a hormone and a neuropeptide, GLP-1 has widespread systemic targets (Holst, 2007) . The role of GLP-1 in glucose metabolism has been studied (Holz et al., 1993) and reviewed (Tolhurst et al., 2008) , and a handful of animal studies have examined GLP-1 as a neuropeptide in the brain. Evidence that GLP-1 is a potent neuropeptide comes from various murine model studies demonstrating that intracerebroventricular administration of GLP-1 modulates activity of the hypothalamus-pituitary-adrenal (HPA) axis. Larsen et al. (1997) showed GLP-1-dependent activation of the HPA axis through corticotrophin releasing factor (CRF) neurons in vivo, a finding replicated by Beak et al. (1998) , who demonstrated GLP-1-dependent activation of hypothalamic GT-1 cells and neurons of the paraventricular nucleus (PVN). Molecular studies also indicate that GLP-1 receptor deficits lead to hyperactivation of the HPA axis, as indexed by increased plasma levels of CRF, vasopressin and corticosterone (MacLusky et al., 2000; Kinzig et al., 2003; Zhang et al., 2009) .
Abnormalities in the HPA axis system marked by cortisol hypersecretion (i.e., hypercortisolemia) are hypothesized to play a role in the etiology and manifestation of various psychiatric conditions, such as major depressive disorder (Bhagwagar et al., 2005) , bipolar disorder (Deshauer et al., 2003) , and anxious traits (Jezova et al., 2004) . HPA axis dysfunction appears to be more than a marker of state psychopathology; indeed, evidence for its etiological significance comes from studies showing that elevated morning cortisol predicts the onset of major depression in youths (Goodyer et al., 2000 (Goodyer et al., , 2009 Halligan et al., 2004) and adults (Harris et al., 2000) . This observed HPA axis abnormality in morning cortisol is thought to have an underlying genetic basis. Family and twin studies support the heritability of HPA function, particularly morning cortisol, such that much of the variance in morning cortisol levels is attributable to heritable factors while cortisol assessed later in the day is not (Bartels et al., 2003; Kupper et al., 2005; Steptoe et al., 2009) . Given the role of GLP-1 in HPA axis activity and the role of HPA axis activity in stress-related disorders, understanding whether genetic Progress in Neuro-Psychopharmacology & Biological Psychiatry 34 (2010) Kinzig et al., 2003; Zhang et al., 2009) , we examined associations between morning and evening cortisol and polymorphic variants of the GLP-1 receptor gene (GLP-1R), located on chromosome 6 of the human genome (OMIM: 138032). In humans, a missense single nucleotide polymorphism (SNP) (rs1042044) is located in exon 7 of the GLP-1R gene, and occurs at a minor allele frequency of greater than 5% in the Caucasian population. This SNP results in an adenine (A) to cytosine (C) change at the sequence level and leucine (Leu) to phenylalanine (Phe) at position 260 of the mature GLP-1R protein (Leu260Phe). As the role of GLP-1R in human stress pathway is unknown, this study is exploratory; however, due to the heritable nature of morning cortisol (Bartels et al., 2003; Kupper et al., 2005; Steptoe et al., 2009 ), we predicted that genetic variation of the GLP-1R gene would be associated with morning cortisol levels, but not with evening cortisol.
Methods

Participants
One hundred and sixty-six children were recruited from a larger community sample participating in a study of temperament and risk for depression. Families of young children were identified using a commercial mailing list. Children between the ages of 3 and 4 years (43.2 ± 2.4 months), with no significant medical or developmental disabilities, and who lived with at least one biological parent were eligible.
Of the 166 families asked to participate in the cortisol assessment study, 87 provided morning and evening salivary cortisol samples on the same day. Average times of morning and evening samplings were 0809 h (SD = 47 min) and 2011 h (SD = 59 min). To maintain population homogeneity, ten children of non-White and unknown ethnicity were excluded from final analysis to yield a final sample of 77 children (47 males). None of the children met criteria for a mood disorder as assessed using the Preschool Age Psychiatric Assessment (PAPA; Egger et al., 1999) . Children were of average cognitive ability as indexed by the Peabody Picture Vocabulary Test (M = 104.42, SD = 13.62; PPVT; Dunn and Dunn, 1997) . The Committees on Research Involving Human Subjects at Stony Brook University approved and oversaw the study. A complete description of the study to parents was provided and written informed consent was obtained.
Saliva collection and cortisol quantification
Parents were given a cortisol collection kit at a laboratory visit. Saliva for cortisol analysis was collected and stored as described by Talge et al. (2005) . Parents were instructed to collect a sample of their child's saliva 30 min after wakening and 30 min before bed, and to avoid feeding their child any food/drink before sampling. Parents were also asked to record the sampling times. Although repeated sampling over several days yields more reliable estimates, and is therefore preferred (Gunnar and Talge, 2008) , the current study collected salivary cortisol samples from children on a single occasion to reduce the burden placed on participants, who were participating in a large scale project with multiple waves of data collection. Nevertheless, moderate stability (r = 0.53) has been demonstrated for home basal cortisol levels (Goldberg et al., 2003) .
Samples were assayed in duplicate using a time-resolved fluorescence immunoassay with fluorometric end-point detection (DELFIA). The inter-and intra-assay coefficients of variation were between 7.1%-9.0% and 4.0%-6.7%, respectively. Consistent with previous research (Talge et al., 2005) , morning and evening cortisol values showed a positively skewed distribution (skewness = 1.31 and 3.03). We applied a log 10 transformation to the data to yield unskewed values (skewness = 0.06 and 0.75). As evening cortisol values were generally less than 1.0 nmol/L, these values were negative after log 10 transformation.
Genotyping
Individual genomic DNA was extracted from buccal swabs (Epicentre, Madison, USA) using the QIAGEN DNA MicroKit® (Valencia, CA) according to the manufacturer's instructions. DNA elutes were kept at +4°C while undergoing genotyping assays and kept at −80°C for long-term storage. The genotyping and cortisol assays were compiled by technicians at two different laboratories and kept blinded from corresponding data sets.
The SNP marker rs1042044 was chosen for this study as it is one of the few non-synonymous variants that exists with a minor allele frequency cut-off of greater than 5% in Caucasian population. The rs1042044 marker was genotyped using TaqMan SNP Genotyping Assays (Applied Biosystems, Foster City, CA) functionally tested by Applied Biosystems (C_2491143). TaqMan polymerase chain reactions (PCR) were performed using 1× ABI TaqMan Genotyping Master Mix, TaqMan 40× probe mix, and 25 ng of DNA, for a 10 µL total volume. The PCR conditions for the TaqMan SNP Genotype Assays were: enzyme activation step at 95.0°C for 10 min, and 50 cycles of denaturation at 95.0°C for 15 s, annealing and extension at 60.0°C for 1 min and a 3 min final extension step. All PCR reactions and allelic discrimination reactions were performed on an ABI StepOne™ RealTime PCR System (Applied Biosystems) and analyzed using SDS v3.0 software (Applied Biosystems). As a quality control measure, all samples were run in duplicates. Additionally, a random subset of the sample (∼10%) was reanalyzed by a technician blind to initial genotyping results. All calls were consistent with initial results. Fourteen children were homozygous for the AA genotype, forty were heterozygous for the AC genotype, and twenty-three were homozygous for the CC genotype. The genotypic distribution is in HardyWeinberg equilibrium (X 2 = 0.219, df = 1, p = 0.634).
Statistical analyses
Multiple group comparisons were performed using one-way analysis of variance (ANOVA) for quantitative outcomes or chi-square tests for categorical variables. The level of significance was set at 0.05 (two-tailed). All statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS, version 16).
Results
GLP-1R SNP genotypes were not associated with child cognitive ability (F = 0.443, df = 2, 74, p = 0.646 or child gender (X 2 = 0.276, df = 2, p = 0.871). Sampling time was not significantly associated with either morning cortisol (r = −0.155, p = 0.193) or evening cortisol levels (r = −0.140, p = 0.262). There was no association between child gender and morning (F = 2.075, df = 1, 75, p = 0.154) or evening cortisol levels (F = 0.856, df = 1, 75, p = 0.358).
Analysis of variance (ANOVA) was used to examine group differences across the three rs1042044 SNP genotypes for morning and cortisol levels. GLP-1R SNP (rs1042044) genotypes were significantly associated with morning (F = 3.024, df=2, 74, p = 0.029) but not with evening cortisol levels (F =0.525, df=2, 74, p =0.594).
1 As seen in Fig. 1 , post-hoc analysis (Tukey's HSD) indicated that children homozygous for the AA genotype had significantly lower mean morning cortisol than those with the AC (mean difference= −0.142, p = 0.044) and CC genotypes (mean difference = −0.161, p = 0.034). In light of the genotypic association with morning cortisol levels, we wanted to see if the associations were allele specific. Indeed, morning cortisol levels were strongly associated with rs1042044, as children carrying either one or two copies of the phenylalanine (C) allele had significantly higher morning cortisol as compared to children homozygous for the leucine (A) allele (F =7.374, df=1, 75, p =0.008).
Discussion
Our results indicate that GLP-1 is associated with HPA axis function in humans. To our knowledge, this is the first study to link a novel genetic variant of GLP-1R gene to HPA axis functioning in humans. Children homozygous for the phenylalanine (C) allele showed significantly higher morning salivary cortisol levels than children homozygous for the leucine (A) allele. These results are consistent with the extant animal model literature where GLP-1 has been shown to influence HPA axis activity (Beak et al., 1998; MacLusky et al., 2000; Kinzig et al., 2003; Zhang et al., 2009) . Our findings also extend the existing literature on the heritability of morning cortisol levels (Bartels et al., 2003; Kupper et al., 2005; Steptoe et al., 2009 ) by identifying a novel genetic marker that may contribute to this phenotype. Although the functionality of rs1042044 is unknown, its position within the gene and mature translated protein indicate that it may be affecting downstream GLP-1 signalling through its receptor GLP-1R. It is also possible that this SNP variant may be capturing functional effects of a flanking linked SNP, and variation at these loci may influence survival and plasticity of stressrelated neurons. Further research is needed to test these hypotheses specifically.
Our study had a few limitations. Our sample size was small, which limited the statistical power of this study. Second, we obtained only a single sample of morning and evening cortisol levels. However, when collecting cortisol samples from young children, caution is needed to avoid compliance issues (Gunnar and Talge, 2008) , which can potentially result in a biased pattern of missing data (e.g., if child compliance is associated with risk for maladjustment). Furthermore, we did not use electronic devices to monitor protocol adherence, which may be a limitation of our study. Finally, we assessed children's morning cortisol levels 30 min after waking, but did not assess the cortisol awakening response (CAR), which is the degree of increase in cortisol during the first 30-40 min post-awakening. However, we were primarily interested in cortisol activity as an index of vulnerability to depression and anxiety, and it is unclear whether the CAR is the optimal index of cortisol activity for this purpose, as there is relatively limited evidence supporting an association between CAR and psychopathology (Jessop and Turner-Cobb, 2008; Chida and Steptoe, 2009) . Recently, Adam et al. (2010) reported that the CAR is a predictor of depression in adolescents; however, more research is needed to confirm this finding. In contrast, a number of reports provide evidence that morning cortisol is a reliable prospective predictor of depressive pathology (Goodyer et al., 2000 (Goodyer et al., , 2009 Harris et al., 2000; Halligan et al., 2004) . Peak cortisol secretion 30 min after awakening is a reliable index of adrenocortical activity in children and adults (Pruessner et al., 1997) and has greater test-retest stability than sampling based on fixed times (Wust et al., 2000) .
The HPA axis has been implicated in the pathophysiology of a number of stress-related disorders (Deshauer et al., 2003; Jezova et al., 2004; Bhagwagar et al., 2005) , but only a handful of studies have identified genetic variants that influence HPA axis functioning and morning cortisol levels in particular (Chen et al., 2009 ). Although our sample was small, we propose that this GLP-1R gene variant, rs1042044, may be a good candidate for future psychiatric studies of genetic markers that contribute to stress sensitivity.
